DOI: 10.1055/s-00035037

Methods of Information in Medicine

LinksSchließen

Referenz

Tapson VF, Torres F, Kermeen F. et al.
Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial.

Chest 2012;
142 (06) 1383-1390

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: